Mednet Logo
CommunityRadiation Oncology

In patients with oligometastatic disease, would you offer SBRT to a metastatic lymph node abutting the trachea and/or esophagus?

If so, what dose and dose constraints would you consider? How would you counsel the patient about risk of trachesophageal fistula?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Mayo Clinic, Rochester
Answered on

I have treated oligometastatic lymph nodes abutting esophagus and trachea. I do not do this routinely and the risks and benefits need to be weighed in terms of whether the patient is truly oligometastatic and if there are potentially effective systemic options.

For these ultracentral locations, I fav...

Join for free or sign in to see the full answer